|
gptkbp:instanceOf
|
gptkb:government_agency
|
|
gptkbp:abbreviation
|
gptkb:EMA
|
|
gptkbp:collaboratesWith
|
gptkb:European_Parliament
gptkb:World_Health_Organization
national competent authorities
|
|
gptkbp:director
|
gptkb:Emer_Cooke
|
|
gptkbp:established
|
1995
|
|
gptkbp:fullName
|
gptkb:European_Medicines_Agency
|
|
gptkbp:fundedBy
|
European Union budget
fees from pharmaceutical industry
|
|
gptkbp:headquartersLocation
|
gptkb:London,_United_Kingdom
gptkb:Amsterdam,_Netherlands
|
|
gptkbp:jurisdiction
|
gptkb:European_Union
|
|
gptkbp:mainLanguage
|
English
|
|
gptkbp:movedToAmsterdam
|
2019
|
|
gptkbp:oversees
|
gptkb:Committee_for_Advanced_Therapies_(CAT)
gptkb:Committee_for_Medicinal_Products_for_Human_Use_(CHMP)
gptkb:Committee_for_Medicinal_Products_for_Veterinary_Use_(CVMP)
gptkb:Committee_for_Orphan_Medicinal_Products_(COMP)
gptkb:Committee_on_Herbal_Medicinal_Products_(HMPC)
gptkb:Pediatric_Committee_(PDCO)
gptkb:Pharmacovigilance_Risk_Assessment_Committee_(PRAC)
|
|
gptkbp:parentOrganization
|
gptkb:European_Union
|
|
gptkbp:regulates
|
human medicines
veterinary medicines
|
|
gptkbp:responsibility
|
pharmacovigilance
evaluation of medicinal products
supervision of medicinal products
authorization of medicines
|
|
gptkbp:role
|
scientific advice
public health protection
publishing guidelines
orphan drug designation
COVID-19 vaccine evaluation
advanced therapies regulation
antimicrobial resistance monitoring
centralized marketing authorization
coordinating EU network of medicines regulators
crisis preparedness and management
herbal medicines evaluation
monitoring medicine safety
pediatric medicines evaluation
rare disease medicines evaluation
supporting innovation in medicines
transparency in medicine evaluation
veterinary medicines evaluation
|
|
gptkbp:website
|
https://www.ema.europa.eu/
|
|
gptkbp:bfsParent
|
gptkb:CSL_Limited
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
EMA (Europe)
|